Nikola’s chairman steps down, stock crashes following allegations of fraudTechCrunch Nikola founder Trevor Milton steps down as executive chairmanCNBC Television Breaking News: Trevor Milton out at Nikola MotorFreightWaves Nikola Doesn’t Look Much Like Tesla NowBloomberg Nikola founder Trevor Milton to voluntarily step down as executive chairman; stock plungesCNBC View Full Coverage on Google News
Business
Trevor Milton Leaves Nikola Motors: FreightWaves – Benzinga
Trevor Milton Leaves Nikola Motors: FreightWavesBenzinga Nikola founder Trevor Milton steps down as executive chairmanCNBC Television Breaking News: Trevor Milton out at Nikola MotorFreightWaves Nikola founder Trevor Milton to voluntarily step down as executive chairman; stock plungesCNBC Nikola founder Trevor Milton steps down as chairman in battle with short sellerCNN View Full Coverage on Google […]
Breaking News: Trevor Milton out at Nikola Motor – FreightWaves
Breaking News: Trevor Milton out at Nikola MotorFreightWaves Nikola founder Trevor Milton steps down as executive chairmanCNBC Television Nikola founder Trevor Milton to voluntarily step down as executive chairman; stock plungesCNBC Nikola founder Trevor Milton steps down as chairman in battle with short sellerCNN Nikola Founder Resigns as Chair Amid Allegations, SEC ProbeBloomberg View Full […]
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer – nejm.org
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancernejm.org Breast cancer drug set to transform prostate cancer treatmentMedical Xpress ESMO: AstraZeneca, Merck’s Lynparza boosts prostate cancer survival by 31% over J&J, Pfizer-Astellas rivalsFiercePharma Pair of prostate cancer drugs found to extend survival timesThe Times View Full Coverage on Google News
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors – nejm.org
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumorsnejm.org Amgen drug shrinks tumors in lung cancer patients with KRAS gene mutation – studyYahoo News Durable responses seen with Amgen’s KRAS-blocking cancer drugSTAT ESMO: Amgen’s KRAS drug tackles 32% of lung cancers—and this is just the beginningFierceBiotech View Full Coverage on Google News